Citadel Advisors - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 152 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$79,093,329
+165.8%
775,729
+137.0%
0.02%
+128.6%
Q1 2023$29,758,753
+83.6%
327,307
-23.3%
0.01%
+75.0%
Q4 2022$16,204,103
+41.4%
426,536
-6.4%
0.00%
+33.3%
Q3 2022$11,456,000
+0.4%
455,915
+21.5%
0.00%0.0%
Q2 2022$11,406,000
-27.9%
375,303
-22.3%
0.00%0.0%
Q1 2022$15,830,000
+71.6%
483,243
+38.2%
0.00%
+200.0%
Q4 2021$9,223,000
-44.7%
349,721
+110.8%
0.00%
-75.0%
Q3 2021$16,691,000
+10.0%
165,893
+54.8%
0.00%0.0%
Q2 2021$15,172,000
+31.3%
107,200
-7.5%
0.00%0.0%
Q1 2021$11,557,000
-1.9%
115,929
+21.6%
0.00%
+33.3%
Q4 2020$11,782,000
-9.0%
95,303
-28.3%
0.00%0.0%
Q3 2020$12,944,000
-28.0%
132,872
+15.4%
0.00%
-50.0%
Q2 2020$17,970,000
-53.0%
115,180
-56.6%
0.01%
-64.7%
Q1 2020$38,267,000
-2.7%
265,121
+37.7%
0.02%0.0%
Q4 2019$39,347,000
+674.5%
192,470
+204.2%
0.02%
+750.0%
Q3 2019$5,080,000
-28.2%
63,272
-15.6%
0.00%
-33.3%
Q2 2019$7,073,000
+33.7%
74,969
+21.1%
0.00%0.0%
Q1 2019$5,291,000
+203.9%
61,897
+99.5%
0.00%
+200.0%
Q4 2018$1,741,000
-68.9%
31,030
-54.7%
0.00%
-66.7%
Q3 2018$5,596,000
+1829.7%
68,462
+726.6%
0.00%
Q2 2018$290,000
-41.6%
8,282
-65.9%
0.00%
Q1 2018$497,000
+94.1%
24,252
+194.6%
0.00%
Q3 2017$256,0008,2320.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders